Daily Stocks News » GSK

Suntory Beverage & Foods Ltd. Buys GlaxoSmithKline’s Lacozade and Ribena Brands

Warren Paige — Mon, 09 Sep 2013 15:43:41 +0000

Japan’s Suntory Beverage & Foods Ltd. has agreed to acquire, Lacozade and Ribena, two soft drink brands from GlaxoSmithKline Plc. (ADR) (NYSE: GSK) in a deal estimated at 1.35 billion pounds or $2.1 billion. The acquisition will allow Suntory, known for its beer and Yamazaki whisky, to beef up its product portfolio and gain traction [...]

GlaxoSmithKline In Final Talks To Sell Locozade and Ribena

Warren Paige — Fri, 06 Sep 2013 15:31:10 +0000

Japan’s Suntory Beverage & Food is in final round of talks with Britain’s leading drug maker, GlaxoSmithKline Plc. ADR (NYSE: GSK) to buy latter’s Locozade and Ribena drinks, said people familiar with the matter. These sources said that Suntory has offered more than 1 billion pounds (about $1.6 billion) to buy these brands. The deal [...]

GlaxoSmithKline Extends Offer for Human Genome Sciences (GSK, HGSI)

Warren Paige — Sat, 09 Jun 2012 12:02:03 +0000

GlaxoSmithKline (NYSE: GSK) has extended its $2.6 billion takeover offer for Human Genome Sciences (NASDAQ: HGSI) until the end of this month. The original tender period expired on June 7. GKS has now extended the tender period to June 29.

GSK said that the tender will now expire at 5 PM EST on June [...]